Evodiamine inhibits RANKL-induced osteoclastogenesis and prevents ovariectomy-induced bone loss in mice (vol 23, pg 522, 2019)

被引:1
|
作者
Jin, H.
Yao, L.
Chen, K.
机构
关键词
D O I
10.1111/jcmm.14374
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
引用
收藏
页码:4850 / 4850
页数:1
相关论文
共 50 条
  • [31] Isoginkgetin Inhibits RANKL-induced Osteoclastogenesis and Alleviates Bone Loss
    Wang, Zihe
    Deng, Wei
    Tang, Kai
    Zhou, Yi
    Chen, Junchun
    Wang, Bin
    Zhang, Zhida
    Zou, Jian
    Zhao, Wenhua
    BIOCHEMICAL PHARMACOLOGY, 2025, 231
  • [32] Xanthotoxin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesis
    Dou, C.
    Chen, Y.
    Ding, N.
    Li, N.
    Jiang, H.
    Zhao, C.
    Kang, F.
    Cao, Z.
    Quan, H.
    Luo, F.
    Xu, J.
    Dong, S.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 (07) : 2335 - 2344
  • [33] Astilbin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesis
    Jin, Haiming
    Wang, Qingqing
    Chen, Kai
    Xu, Ke
    Pan, Hao
    Chu, Feifan
    Ye, Zhen
    Wang, Ziyi
    Tickner, Jennifer
    Qiu, Heng
    Wang, Chao
    Kenny, Jacob
    Xu, Huazi
    Wang, Te
    Xu, Jiake
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23 (12) : 8355 - 8368
  • [34] Xanthotoxin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesis
    C. Dou
    Y. Chen
    N. Ding
    N. Li
    H. Jiang
    C. Zhao
    F. Kang
    Z. Cao
    H. Quan
    F. Luo
    J. Xu
    S. Dong
    Osteoporosis International, 2016, 27 : 2335 - 2344
  • [35] Cytisine attenuates bone loss of ovariectomy mouse by preventing RANKL-induced osteoclastogenesis
    Qian, Zhi
    Zhong, Zeyuan
    Ni, Shuo
    Li, Dejian
    Zhang, Fangxue
    Zhou, Ying
    Kang, Zhanrong
    Qian, Jun
    Yu, Baoqing
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (17) : 10112 - 10127
  • [36] Sappanone A inhibits RANKL-induced osteoclastogenesis in BMMs and prevents inflammation-mediated bone loss
    Choo, Young-Yeon
    Phuong Thao Tran
    Min, Byung-Sun
    Kim, Okwha
    Nguyen, Hai Dang
    Kwon, Seung-Hae
    Lee, Jeong-Hyung
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2017, 52 : 230 - 237
  • [37] Celastrol Attenuates RANKL-Induced Osteoclastogenesis in vitro and Reduces Titanium Particle-Induced Osteolysis and Ovariectomy-Induced Bone Loss in vivo
    Xu, Qiang
    Chen, Guiping
    Xu, Huaen
    Xia, Guoming
    Zhu, Meisong
    Zhan, Haibo
    Zhang, Bin
    Dai, Min
    Fan, Hongxian
    Liu, Xuqiang
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [38] Shikonin mitigates ovariectomy-induced bone loss and RANKL-induced osteoclastogenesis via TRAF6-mediated signaling pathways
    Chen, Kai
    Yan, Zijun
    Wang, Yiran
    Yang, Yilin
    Cai, Mengxi
    Huang, Chunyou
    Li, Bo
    Yang, Mingyuan
    Zhou, Xiaoyi
    Wei, Xianzhao
    Yang, Changwei
    Chen, Ziqiang
    Zhai, Xiao
    Li, Ming
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 126
  • [39] Artesunate inhibits RANKL-induced osteoclastogenesis and bone resorption in vitro and prevents LPS-induced bone loss in vivo
    Wei, Cheng-Ming
    Liu, Qian
    Song, Fang-Ming
    Lin, Xi-Xi
    Su, Yi-Ji
    Xu, Jiake
    Huang, Lin
    Zong, Shao-Hui
    Zhao, Jin-Min
    JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (01) : 476 - 485
  • [40] Meclizine Prevents Ovariectomy-Induced Bone Loss and Inhibits Osteoclastogenesis Partially by Upregulating PXR (vol 8, 693, 2017)
    Guo, Jiachao
    Li, Weijin
    Wu, Yingxing
    Jing, Xingzhi
    Huang, Junming
    Zhang, Jiaming
    Xiang, Wei
    Ren, Ranyue
    Lv, Zhengtao
    Xiao, Jun
    Guo, Fengjing
    FRONTIERS IN PHARMACOLOGY, 2018, 8